Literature DB >> 12457044

Common eye diseases of elderly people: identifying and treating causes of vision loss.

Patricia T Harvey1.   

Abstract

Of the 38 million people who are blind, the majority, 22 million, are 60 years of age or older. The most common causes of vision loss in elderly people are age-related macular degeneration (AMD), cataract, glaucoma, and diabetic retinopathy. Of these, AMD is the leading cause of registered blindness in people over the age of 50 years in the western world. However, until recently, the treatment options for people with AMD have been severely limited. Verteporfin therapy is a new treatment that is efficacious and safe in selected patients with AMD who are at high risk of central vision loss. Physicians who are in regular contact with elderly people can help to minimize vision loss in this group of patients by being alert to the symptoms and signs of age-related eye diseases. This paper reviews each of the common eye diseases, with an emphasis on AMD because of the recent advances in treatment. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12457044     DOI: 10.1159/000066507

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  14 in total

1.  Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

Authors:  Sudha K Iyengar; Danhong Song; Barbara E K Klein; Ronald Klein; James H Schick; Jennifer Humphrey; Christopher Millard; Rachel Liptak; Karlie Russo; Gyungah Jun; Kristine E Lee; Bonnie Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

2.  (R)-alpha-lipoic acid protects retinal pigment epithelial cells from oxidative damage.

Authors:  Ludmila A Voloboueva; Jiankang Liu; Jung H Suh; Bruce N Ames; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

3.  Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial.

Authors:  B C Reeves; R A Harper; W B Russell
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

4.  Comparison of the efficacy of anti-VEGF monotherapy versus PDT and intravitreal anti-VEGF combination treatment in AMD: a Meta-analysis and systematic review.

Authors:  Yao Tong; Ke-Ke Zhao; Dong Feng; Manas Biswal; Pei-Quan Zhao; Zhao-Yang Wang; Yun Zhang
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

5.  N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration.

Authors:  Ludmila A Voloboueva; David W Killilea; Hani Atamna; Bruce N Ames
Journal:  FASEB J       Date:  2007-07-26       Impact factor: 5.191

Review 6.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

7.  The direction of research into visual disability and quality of life in glaucoma.

Authors:  Fiona C Glen; David P Crabb; David F Garway-Heath
Journal:  BMC Ophthalmol       Date:  2011-08-04       Impact factor: 2.209

8.  Conditional knockout of hephaestin in the neural retina disrupts retinal iron homeostasis.

Authors:  Kevin R Zhang; Bailey Baumann; Ying Song; Jacob Sterling; Elizabeth A Erler; Samyuktha Guttha; Zbynek Kozmik; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2022-03-08       Impact factor: 3.770

9.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

10.  Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells.

Authors:  Yuan He; Kar Wah Leung; Ye-Hong Zhuo; Jian Ge
Journal:  Mol Vis       Date:  2009-04-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.